Quant Healthcare Fund - Growth Option - Direct Plan
Quant Money Managers Limited · Direct Plan · Growth
Fund overview
1% on or before 15D, Nil after 15D
Returns & rankings
| Period | Fund Returns | Category Avg. | Rank | VS Category |
|---|---|---|---|---|
| … | ||||
Green = fund outperformed the category average for that period; red = underperformed. Periods under 1 year always show absolute (non-annualised) returns. Past performance does not guarantee future returns.
Return calculator
One-time investment
₹5,000
| Over the past | Total investment | Would've become | Returns |
|---|---|---|---|
| 1 Year | ₹5,000 | ₹5,966 | +966 |
| 3 Years | ₹5,000 | ₹8,494 | +3,494 |
| 5 Years | ₹5,000 | ₹12,094 | +7,094 |
Calculated using the fund's annualised return since inception (19.3% p.a.) as period-wise historical returns aren't available in the current feed. Actual returns fluctuate and are not guaranteed. Mutual fund investments are subject to market risks.
Holdings
26 securitiesTop 10 holdings make up 95.9% of the portfolio.
| Security | Sector | Market Cap | Weight |
|---|---|---|---|
| TREPS 01-Oct-2026 DEPO 10 | Cash/Deposits/Margins/Treps/Repo/Swaps | — | 26.57% |
| Glaxosmithkline Pharmaceuticals Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 9.69% |
| Divi'S Laboratories Ltd | Pharmaceuticals & Biotechnology | Large Cap | 9.63% |
| Zydus Lifesciences Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 9.39% |
| Glenmark Pharmaceuticals Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 9.34% |
| Strides Pharma Science Ltd | Pharmaceuticals & Biotechnology | Small Cap | 9.04% |
| Torrent Pharmaceuticals Ltd | Pharmaceuticals & Biotechnology | Large Cap | 8.62% |
| Pfizer Ltd | Pharmaceuticals & Biotechnology | Small Cap | 7.37% |
| Glenmark Life Sciences Ltd | Pharmaceuticals & Biotechnology | Small Cap | 6.21% |
| Ipca Laboratories Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 5.98% |
Portfolio Allocation
Equity / Debt / Cash
Total Value
₹425 Cr
Market Cap Split
Total Value
100%
Equity sector allocation
Total Value
₹422 Cr
Debt sector allocation
Total Value
₹27 Cr
Allocation By Credit Quality (Debt)
Exit load, stamp duty & tax
17-Jul-23
1% on or before 15D, Nil after 15D
0.005% (from July 1st, 2020)
Taxation depends on the fund category and holding period. Consult the scheme document or a tax advisor for details.
Risk & Performance Ratios (1Y)
| Standard Deviation | -- |
| Beta | -- |
| Sharpe Ratio | -- |
| Sortino Ratio | -- |
| Treynor Ratio | -- |
| Jensen's Alpha | -- |
| Information Ratio | -- |
| R-Squared | -- |
| Max Drawdown | -- |
| Upside Capture | -- |
| Downside Capture | -- |
Fund management
Scheme Details
Investment objective
The Investment Objective Of The Scheme Is To Seek Long Term Capital Appreciation By Investing In Equity/Equity Related Instruments Of Companies From The Healthcare Sector. However, There Is No Assurance Or Guarantee That The Investment Objective Of The Scheme Will Be Achieved.
Fund house
Quant Money Managers Limited
Frequently asked questions
What is the NAV of Quant Healthcare Fund - Growth Option - Direct Plan?
The NAV of Quant Healthcare Fund - Growth Option - Direct Plan is ₹17.81 as of 21 Oct 2026. NAV is updated at the end of every trading day.
How much expense ratio is charged by Quant Healthcare Fund - Growth Option - Direct Plan?
The expense ratio charged by Quant Healthcare Fund - Growth Option - Direct Plan is 1.51%.
What is the Min. SIP of Quant Healthcare Fund - Growth Option - Direct Plan?
The minimum SIP investment in Quant Healthcare Fund - Growth Option - Direct Plan is ₹1,000 per month.
What is the Min. Lumpsum of Quant Healthcare Fund - Growth Option - Direct Plan?
The minimum lumpsum investment in Quant Healthcare Fund - Growth Option - Direct Plan is ₹5,000.
What is the Exit Load of Quant Healthcare Fund - Growth Option - Direct Plan?
The exit load for Quant Healthcare Fund - Growth Option - Direct Plan is: 1% on or before 15D, Nil after 15D
.svg){kind=small}